RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. Issue 2 (December 2015) - Hu, Xiao; Moisan, Jacques; Majchrzak, Kinga; Lesch, Chuck; Wang, Yahong; Sanchez, Brian; Liu, Xikui; Morgan, Rodney; Mertz, David; Bousley, Dick; van Huis, Chad; Skalitzky, Don; et al.